Literature DB >> 28921803

The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis.

Søren Møller1, Flemming Bendtsen2.   

Abstract

Patients with cirrhosis and portal hypertension often develop complications from a variety of organ systems leading to a multiple organ failure. The combination of liver failure and portal hypertension results in a hyperdynamic circulatory state partly owing to simultaneous splanchnic and peripheral arterial vasodilatation. Increases in circulatory vasodilators are believed to be due to portosystemic shunting and bacterial translocation leading to redistribution of the blood volume with central hypovolemia. Portal hypertension per se and increased splanchnic blood flow are mainly responsible for the development and perpetuation of the hyperdynamic circulation and the associated changes in cardiovascular function with development of cirrhotic cardiomyopathy, autonomic dysfunction and renal dysfunction as part of a cardiorenal syndrome. Several of the cardiovascular changes are reversible after liver transplantation and point to the pathophysiological significance of portal hypertension. In this paper, we aimed to review current knowledge on the pathophysiology of arterial vasodilatation and the hyperdynamic circulation in cirrhosis.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cardiac dysfunction; liver failure; multi-organ syndrome; portal hypertension

Mesh:

Substances:

Year:  2018        PMID: 28921803     DOI: 10.1111/liv.13589

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  29 in total

Review 1.  Acute kidney injury: prediction, prognostication and optimisation for liver transplant.

Authors:  Nishita Jagarlamudi; Florence Wong
Journal:  Hepatol Int       Date:  2020-03-03       Impact factor: 6.047

2.  Terlipressin and albumin combination treatment in patients with hepatorenal syndrome type 2.

Authors:  Marc Nguyen-Tat; Julia Jäger; Johannes Wilhelm Rey; Michael Nagel; Christian Labenz; Marcus-Alexander Wörns; Peter Robert Galle; Jens Uwe Marquardt
Journal:  United European Gastroenterol J       Date:  2019-02-20       Impact factor: 4.623

3.  The Clinical Impact of Cirrhosis on the Hospital Outcomes of Patients Admitted With Influenza Infection: Propensity Score Matched Analysis of 2011-2017 US Hospital Data.

Authors:  David U Lee; Gregory H Fan; David J Hastie; Vibhav N Prakasam; Elyse A Addonizio; Ryan R Ahern; Kristen J Seog; Raffi Karagozian
Journal:  J Clin Exp Hepatol       Date:  2021-02-04

4.  Fractional Excretion of Sodium and Urea in Differentiating Acute Kidney Injury Phenotypes in Decompensated Cirrhosis.

Authors:  Yashavanth H S Gowda; Nitin Jagtap; Arun Karyampudi; Nagaraja P Rao; Gujjarapudi Deepika; Mithun Sharma; Rajesh Gupta; Manu Tandan; Mohan Ramchandani; Priyadarshini John; Anand Kulkarni; Pramod Kumar; Bhushan Bhaware; Mohan V Turpati; D Nageshwar Reddy
Journal:  J Clin Exp Hepatol       Date:  2021-09-28

5.  Sex Differences in the Regulation of Vasopressin and Oxytocin Secretion in Bile Duct Ligated Rats.

Authors:  Kirthikaa Balapattabi; Joel T Little; Martha E Bachelor; Rebecca L Cunningham; J Thomas Cunningham
Journal:  Neuroendocrinology       Date:  2020-04-24       Impact factor: 4.914

Review 6.  Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications.

Authors:  Csaba Matyas; György Haskó; Lucas Liaudet; Eszter Trojnar; Pal Pacher
Journal:  Nat Rev Cardiol       Date:  2020-09-30       Impact factor: 32.419

7.  Exercise Training Attenuates Cirrhotic Cardiomyopathy.

Authors:  Sérgio Luiz Borges de Souza; Gustavo Augusto Ferreira Mota; Cristina Schmitt Gregolin; Milena do Nascimento; Renata Azevedo Melo Luvizotto; Silmeia Garcia Zanati Bazan; Mário Mateus Sugizaki; Luis Fernando Barbisan; Antonio Carlos Cicogna; André Ferreira do Nascimento
Journal:  J Cardiovasc Transl Res       Date:  2020-04-03       Impact factor: 4.132

8.  Risk Factors of Atrial Arrhythmia in Patients With Liver Cirrhosis: A Retrospective Study.

Authors:  Xiya Lu; Zhijing Wang; Liu Yang; Changqing Yang; Meiyi Song
Journal:  Front Cardiovasc Med       Date:  2021-07-05

9.  Outcomes of Portal Pressure-Guided Therapy in Decompensated Cirrhosis With Index Variceal Bleed in Asian Cohort.

Authors:  Sanchit Sharma; Samagra Agarwal; Deepak Gunjan; Kanav Kaushal; Abhinav Anand; Srikant Gopi; Srikant Mohta; Anoop Saraya
Journal:  J Clin Exp Hepatol       Date:  2020-11-13

10.  Using MR elastography to assess portal hypertension and response to beta-blockers in patients with cirrhosis.

Authors:  Karen Vagner Danielsen; Jens Dahlgaard Hove; Puria Nabilou; Meng Yin; Jun Chen; Mirabella Zhao; Thomas Kallemose; Ane Søgaard Teisner; Hartwig Roman Siebner; Richard L Ehman; Søren Møller; Flemming Bendtsen
Journal:  Liver Int       Date:  2021-06-16       Impact factor: 8.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.